Rating History for Cardiol Therapeutics (CRDL) by Brookline Capital Markets
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 9/17/2025 | Tyler Bussian | New Coverage | Buy (N/A) |
6.00 (N/A) |
1.08 (1.04) |
-3.7% | Details |
